TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Trius Therapeutics, Inc. (NASDAQ:TSRX) Investor Files Lawsuit Against Buyout By Cubist Pharmaceuticals

  • If you purchased shares of the Trius Therapeutics, Inc. (NASDAQ:TSRX) and currently hold any of those NASDAQ:TSRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

August 2, 2013 (Shareholders Foundation) - An investor, who currently holds shares of Trius Therapeutics, Inc. (NASDAQ:TSRX), filed a lawsuit in effort to halt the proposed takeover of Trius Therapeutics, Inc. by Cubist Pharmaceuticals, Inc. The plaintiff alleges that the defendants breached their fiduciary duties by agreeing to sell the company at an unfair price via an unfair proce...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: